The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Open accessAbstract
Objective: To evaluate quantitatively articles that compared effects of second and third generation oral contraceptives on risk of venous thrombosis. Design: Meta-analysis. Studies: Cohort and case-control studies assessing risk of venous thromboembolism among women using oral contraceptives before October 1995. Main outcome measures: Pooled adjusted odds ratios calculated by a general variance based random effects method. When possible, two by two tables were extracted and combined by the Mantel-Haenszel method. Results: The overall adjusted odds ratio for third versus second generation oral contraceptives was 1.7 (95% confidence interval 1.4 to 2.0; seven studies). Similar risks were found when oral contraceptives containing desogestrel or gestodene were compared with those containing levonorgestrel. Among first time users, the odds ratio for third versus second generation preparations was 3.1 (2.0 to 4.6; four studies). The odds ratio was 2.5 (1.6 to 4.1; five studies) for short term users compared with 2.0 (1.4 to 2.7; five studies) for longer term users. The odds ratio was 1.3 (1.0 to 1.7) in studies funded by the pharmaceutical industry and 2.3 (1.7 to 3.2) in other studies. Differences in age and certainty of diagnosis of venous thrombosis did not affect the results. Conclusions: This meta-analysis supports the view that third generation oral contraceptives are associated with an increased risk of venous thrombosis compared with second generation oral contraceptives. The increase cannot be explained by several potential biases. What is already known on this topic: Third generation oral contraceptives have been reported to increase the risk of venous thrombosis compared with second generation oral contraceptives The findings have been vigorously debated, with suggestions that the results can be explained by confounding or bias, or both. What this study adds: Women taking third generation oral contraceptives have a 1.7-fold increased risk of venous thrombosis compared with those taking second generation oral contraceptives Risk is highest in first time users The biases were not large enough to account for the observed results
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis
Petitti, D. B. (1999) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195133646.001.0001 · Cited by 925
Jick, H., Jick, S. S., Myers, M. W., Vasilakis, C., & Gurewich, V (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 726
Conflict of Interest in the Debate over Calcium-Channel Antagonists
Stelfox, H. T., Chua, G., O'Rourke, K., & Detsky, A. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380206 · Cited by 615
Spitzer, W. O., Lewis, M. A., Heinemann, L. A. J., Thorogood, M., & MacRae, K. D. (1996) · BMJ · doi:10.1136/bmj.312.7023.83 · Cited by 594
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Büller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 580
Oral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
Statistical Methods in Meta-Analysis
Petitti, D. B. (1999) · Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis · doi:10.1093/acprof:oso/9780195133646.003.07 · Cited by 287
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420020059007 · Cited by 277
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.2.157 · Cited by 274
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
First-time use of newer oral contraceptives and the risk of venous thromboembolism
Suissa, S., Blais, L., Spitzer, W. O., Cusson, J., Lewis, M., & Heinemann, L. (1997) · Contraception · doi:10.1016/s0010-7824(97)00119-4 · Cited by 191
Oral contraceptives and venous thromboembolism
Lidegaard, Ø., Edström, B., & Kreiner, S. (1998) · Contraception · doi:10.1016/s0010-7824(98)00033-x · Cited by 186
Lewis, M. A., Heinemann, L. A. J., MacRae, K. D., Bruppacher, R., & Spitzer, W. O. (1996) · Contraception · doi:10.1016/0010-7824(96)00112-6 · Cited by 183
Gullen, W. H. (1978) · JAMA · doi:10.1001/jama.1978.03280520027003 · Cited by 174
Martinelli, I., Taioli, E., Bucciarelli, P., Akhavan, S., & Mannucci, P. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.700 · Cited by 172
Bloemenkamp, K. W. M., Rosendaal, F. R., Buller, H. R., Helmerhorst, F. M., Colly, L. P., & Vandenbroucke, J. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.65 · Cited by 141
Farmer, R. D. T., Lawrenson, R. A., Todd, J. ‐., Williams, T. J., MacRae, K. D., Tyrer, F., & Leydon, G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00198.x · Cited by 130
Confounding and indication for treatment in evaluation of drug treatment for hypertension
Grobbee, D. E., & Hoes, A. W. (1997) · BMJ · doi:10.1136/bmj.315.7116.1151 · Cited by 129
Self-citationVenous thromboembolism amng new users of different oral contraceptives.
Herings, R. M. C., Urquhart, J., & Leufkens, H. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01257-x · Cited by 128
The risk of venous thromboembolism in users of postcoital contraceptive pills
Vasilakis‐Scaramozza, C., Jick, S. S., & Jick, H. (1999) · Contraception · doi:10.1016/s0010-7824(99)00011-6 · Cited by 127
Newer Oral Contraceptives and the Risk of Venous Thromboembolism
Walker, A. M. (1998) · Contraception · doi:10.1016/s0010-7824(98)00014-6 · Cited by 104
The differential risk of oral contraceptives: the impact of full exposure history*
Lewis, M. A., MacRae, K. D., Kühl-Habich, D., Bruppacher, R., Heinemann, L. A. J., & Spitzer, W. O. (1999) · Human Reproduction · doi:10.1093/humrep/14.6.1493 · Cited by 80
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism
Suissa, S., Spitzer, W. O., Rainville, B., Cusson, J., Lewis, M., & Heinemann, L. (2000) · Human Reproduction · doi:10.1093/humrep/15.4.817 · Cited by 80
Farley, T. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.6.721 · Cited by 77
Vandenbroucke, J. P., Helmerhorst, F. M., Bloemenkamp, K. W. M., & Rosendaal, F. R. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70289-8 · Cited by 73
Smoking and use of oral contraceptives: Impact on thrombotic diseases
Lidegaard, Ø. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70696-4 · Cited by 71
Conflict of Interest in the Debate Over Calcium-Channel Antagonists
Stelfox, H. T., Chua, G., ROURKE, K. O., & Detsky, A. S. (1998) · Survey of Anesthesiology · doi:10.1097/00132586-199812000-00057 · Cited by 64
Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies
Lidegaard, Ø., & Milsom, I. (1996) · Contraception · doi:10.1016/0010-7824(96)00035-2 · Cited by 62
Todd, J. ‐., Lawrenson, R. A., Farmer, R. D. T., Williams, T. J., & Leydon, G. (1999) · Human Reproduction · doi:10.1093/humrep/14.6.1500 · Cited by 61
Andersen, B. S., Olsen, J., Nielsen, G. L., Steffensen, F. H., Sørensen, H. T., Bæch, J., & Gregersen, H. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614213 · Cited by 57
Farmer, R. D. T., Lawrenson, R. A., Todd, J. C., Williams, T. J., & MacRae, K. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.6.688 · Cited by 53
Farmer, R. D. T., Todd, J. ‐., Lewis, M. A., MacRae, K. D., & Williams, T. J. (1998) · Contraception · doi:10.1016/s0010-7824(98)00002-x · Cited by 49
Fluorouracil and folinic acid in colon cancer
Hughes‐Davies, L., Rescigno, J., & Marsoni, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91136-7 · Cited by 45
van Lunsen, H. W. (1996) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189609150654 · Cited by 30
Bennet, L., & Odeberg, H. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00310.x · Cited by 29
Lidegaard, Ø. (1997) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.1997.tb07855.x · Cited by 28
Selective prescribing of third generation oral contraceptives (OCs)
Jamin, C., & de Mouzon, J. (1996) · Contraception · doi:10.1016/0010-7824(96)00120-5 · Cited by 27
Lewis, M. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.6.707 · Cited by 24
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89712-8 · Cited by 24
Farmer, R. D. T., & Lawrenson, R. A. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1053/ob.1998.v179.a92634 · Cited by 22
Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies
Farley, T. M. M., Meirik, O., Poulter, N. R., Chang, C. L., & Marmot, M. G. (1996) · Contraception · doi:10.1016/s0010-7824(96)00166-7 · Cited by 21
The influence of thrombotic risk factors when oral contraceptives are prescribed
Scandinavica, G. (1997) · Cited by 18
Scoring the Quality of Clinical Trials
Vandenbroucke, J. P. (2000) · JAMA · doi:10.1001/jama.283.11.1421-b · Cited by 7
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Self-citationPharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Metadata
- Authors
- Kemmeren, J. M., Algra, A., & Grobbee, D. E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2001-07-21
- Volume
- 323
- Issue
- 7305
- Pages
- 131
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2113184125
- Cited by
- 455
- References
- 49
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.